{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:41:41Z","timestamp":1791416501400,"version":"4.3.3"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077587","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T21:17:26Z","timestamp":1381958246000},"page":"e77587","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Statin Use and Markers of Immunity in the Doetinchem Cohort Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Hilda J.I.","family":"De Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.M.C.","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"Vandebriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Souverein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Gremmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Van Loveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.M. Monique","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"C Baigent","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: Focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"S Bellosta","year":"2004","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial--lipid lowering arm (ASCOT-LLA): A multicentre randomised controlled trial","volume":"361","author":"PS Sever","year":"2003","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: Anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"BR Kwak","year":"2003","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tcm.2005.07.002","article-title":"Toward immunomodulatory and anti-inflammatory properties of statins","volume":"15","author":"C Arnaud","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejphar.2005.05.005","article-title":"Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis","volume":"516","author":"MM Barsante","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1000336","DOI":"10.1371\/journal.pmed.1000336","article-title":"Persistence with statins and onset of rheumatoid arthritis: A population-based cohort study","volume":"7","author":"G Chodick","year":"2010","journal-title":"PLOS Med"},{"key":"ref8","first-page":"1083","article-title":"Bone protective effect of simvastatin in experimental arthritis","volume":"35","author":"JL Funk","year":"2008","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard.2008.091967","article-title":"Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis","volume":"68","author":"SS Jick","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"BP Leung","year":"2003","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of atorvastatin in rheumatoid arthritis (TARA): Double-blind, randomised placebo-controlled trial","volume":"363","author":"DW McCarey","year":"2004","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-006-0270-9","article-title":"Effects of pravastatin in murine collagen-induced arthritis","volume":"27","author":"T Yamagata","year":"2007","journal-title":"Rheumatol Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.autrev.2011.04.030","article-title":"Management of refractory anti-phospholipid syndrome","volume":"10","author":"T Scoble","year":"2011","journal-title":"Autoimmun Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clim.2010.03.008","article-title":"Effect of combining ACE inhibitor and statin in lupus-prone mice","volume":"136","author":"H Shimazu","year":"2010","journal-title":"Clin Immunol"},{"key":"ref15","first-page":"2361","article-title":"Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: A role for the HMG-CoA reductase inhibitor simvastatin","volume":"33","author":"PJ Kotyla","year":"2006","journal-title":"J Rheumatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/rheumatology\/kem381","article-title":"Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: An 8 week controlled trial","volume":"47","author":"PJ Kotyla","year":"2008","journal-title":"Rheumatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.4049\/jimmunol.173.12.7641","article-title":"Atorvastatin inhibits autoreactive B cell activation and delays lupus development in new zealand black\/white F1 mice","volume":"173","author":"S Lawman","year":"2004","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kem186","article-title":"Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: An 8 weeks controlled trial","volume":"46","author":"GA Ferreira","year":"2007","journal-title":"Rheumatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1191\/0961203303lu429oa","article-title":"Therapy with statins in patients with refractory rheumatic diseases: A preliminary study","volume":"12","author":"C Abud-Mendoza","year":"2003","journal-title":"Lupus"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"S Khattri","year":"2013","journal-title":"Immunol Res"},{"key":"ref21","author":"J Kay","year":"2006"},{"key":"ref22","first-page":"294","article-title":"[Polymyositis induced or associated with lipid-lowering drugs: Five cases]","volume":"25","author":"AL Fauchais","year":"2004","journal-title":"Rev M\u00e9d Interne"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"MC Dalakas","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: A systematic review","volume":"21","author":"B No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1111\/j.1756-185X.2010.01481.x","article-title":"ANCA-positive vasculitis associated with simvastatin\/ezetimibe: Expanding the spectrum of statin-induced autoimmunity?","author":"D Sen","year":"2010"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2011.155622","article-title":"Use of statins is associated with an increased risk of rheumatoid arthritis","volume":"71","author":"HJ De Jong","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e41289","DOI":"10.1371\/journal.pone.0041289","article-title":"Statin-associated polymyalgia rheumatica. an analysis using WHO global individual case safety database: A Case\/Non-case approach","volume":"7","author":"HJ De Jong","year":"2012","journal-title":"PLOS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2011.06.002","article-title":"Association between statin use and lupus-like syndrome using spontaneous reports","volume":"41","author":"HJ De Jong","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar3814","article-title":"Statins accelerate the onset of collagen type II-induced arthritis in mice","volume":"14","author":"RJ Vandebriel","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"B Kwak","year":"2000","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"SE Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"PM Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2796.2010.02230.x","article-title":"C-reactive protein lowering with rosuvastatin in the METEOR study","volume":"268","author":"SAE Peters","year":"2010","journal-title":"J Intern Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000126063","article-title":"HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells","volume":"146","author":"S Kagami","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"ref35","first-page":"463","article-title":"Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"33","author":"K Yokota","year":"2006","journal-title":"J Rheumatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1515\/CCLM.2003.200","article-title":"HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease","volume":"41","author":"RB Walter","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"S Youssef","year":"2002","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.169.1.407","article-title":"Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells","volume":"169","author":"JL Lordan","year":"2002","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/cimm.1993.1153","article-title":"IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: Comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304)","volume":"149","author":"E Brummer","year":"1993","journal-title":"Cell Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2004.08.037","article-title":"Statins and autoimmune diseases","volume":"4","author":"VS Gurevich","year":"2005","journal-title":"Autoimmun Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ije\/dym292","article-title":"Cohort profile: The doetinchem cohort study","volume":"37","author":"WMM Verschuren","year":"2008","journal-title":"Int J Epidemiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jech.46.2.136","article-title":"Pharmaco-morbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts","volume":"46","author":"RM Herings","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"ref43"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis","volume":"326","author":"MR Law","year":"2003","journal-title":"BMJ"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association","volume":"107","author":"TA Pearson","year":"2003","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/oby.2010.337","article-title":"Abdominal fat mass is associated with adaptive immune activation: The CODAM study","volume":"19","author":"MM Thewissen","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1158\/1078-0432.CCR-06-2819","article-title":"Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma","volume":"13","author":"GME Matta","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2005.05.007","article-title":"From ANA to ENA: How to proceed?","volume":"5","author":"JG Damoiseaux","year":"2006","journal-title":"Autoimmun Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1196\/annals.1381.027","article-title":"Type II cryoglobulinemia is not associated with hepatitis C infection: The dutch experience","volume":"1107","author":"JWC Tervaert","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BOR.0b013e32832f13db","article-title":"Drug-induced autoimmunity","volume":"21","author":"F Dedeoglu","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/oxfordjournals.aje.a115409","article-title":"the impact of confounder selection criteria on effect estimation","volume":"130","author":"S Greenland","year":"1989","journal-title":"Am J Epidemiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F","article-title":"Sympercents: Symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data","volume":"19","author":"TJ Cole","year":"2000","journal-title":"Stat Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-4731(90)90270-3","article-title":"Effects of gender and sex steroids on the immune response","volume":"35","author":"AH Schuurs","year":"1990","journal-title":"J Steroid Biochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1997.tb01022.x","article-title":"Aging and the immune system","volume":"160","author":"RJ Hodes","year":"1997","journal-title":"Immunol Rev"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls","volume":"338","author":"JA Sterne","year":"2009","journal-title":"BMJ"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5551\/jat.5652","article-title":"Effects of statins on serum inflammatory markers: The U.S. national health and nutrition examination survey 1999-2004","volume":"17","author":"SS Yoon","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2011.07.117","article-title":"Association of statins with inflammatory cytokines: A population-based Colaus study","volume":"219","author":"T Lyngdoh","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2006.06.022","article-title":"Effects of simvastatin on human T cells in vivo","volume":"193","author":"P Cherfan","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation\/CRP evaluation (PRINCE): A randomized trial and cohort study","volume":"286","author":"MA Albert","year":"2001","journal-title":"JAMA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"PM Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1073\/pnas.0508492103","article-title":"Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells","volume":"103","author":"M Arora","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0091-6749(95)70109-5","article-title":"Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia","volume":"95","author":"CK Fosso","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10557-007-6010-x","article-title":"The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress","volume":"21","author":"DJ Mulder","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2004.02.016","article-title":"Statin-induced immunomodulatory effects on human T cells in vivo","volume":"175","author":"T Fehr","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0953-6205(01)00172-8","article-title":"Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein","volume":"12","author":"PL Van Haelst","year":"2001","journal-title":"Eur J Intern Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.62.4.353","article-title":"Regional differences in finland in the prevalence of rheumatoid factor in the presence and absence of arthritis","volume":"62","author":"T Korpil\u00e4hde","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in &quot;healthy&quot; individuals","volume":"40","author":"EM Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in england and wales: Population based cohort study using the QResearch database","volume":"340","author":"J Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2125.2008.03308.x","article-title":"Effect of statins on a wide range of health outcomes: A cohort study validated by comparison with randomized trials","volume":"67","author":"L Smeeth","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"AL Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"AL Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0301-472X(03)00192-9","article-title":"Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9","volume":"31","author":"D Chapman-Shimshoni","year":"2003","journal-title":"Exp Hematol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/CRIAI:25:1:49","article-title":"Systemic lupus erythematosus and apoptosis: A question of balance","volume":"25","author":"D Mevorach","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfg485","article-title":"Deranged removal of apoptotic cells: Its role in the genesis of lupus","volume":"19","author":"JW Dieker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/rheumatology\/39.6.581","article-title":"Antinuclear antibodies: Cause of disease or caused by disease?","volume":"39","author":"RJ Smeenk","year":"2000","journal-title":"Rheumatology (Oxf)"},{"key":"ref76","first-page":"1","article-title":"Autoimmune disease: Mechanisms","year":"2007"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1056\/NEJMp078083","article-title":"Mevalonate kinase deficiency and autoinflammatory disorders","volume":"356","author":"D Haas","year":"2007","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ncpneph0217","article-title":"Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?","volume":"2","author":"S Steffens","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1074\/jbc.M401245200","article-title":"Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta","volume":"279","author":"P Schotte","year":"2004","journal-title":"J Biol Chem"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.176.9.5284","article-title":"Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes","volume":"176","author":"WR Coward","year":"2006","journal-title":"J Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity","volume":"186","author":"SJ Lalor","year":"2011","journal-title":"J Immunol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10545-010-9173-8","article-title":"Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency","volume":"33","author":"L Henneman","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"ref83","article-title":"The; Lancet","year":"2012"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/intimm\/dxp037","article-title":"Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3 regulatory T cells","volume":"21","author":"S Kagami","year":"2009","journal-title":"Int Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","article-title":"The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells","volume":"197","author":"K Mausner-Fainberg","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2119\/molmed.2011.00471","article-title":"Statins induce the accumulation of regulatory T cells in atherosclerotic plaque","volume":"18","author":"X Meng","year":"2012","journal-title":"Mol Med"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.thromres.2004.12.005","article-title":"Comparison of soluble thrombomodulin, von willebrand factor, tPA\/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (stabilyte) stored at -70 degrees C for 8-11 years","volume":"116","author":"TK Nilsson","year":"2005","journal-title":"Thromb Res"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CDLI.6.1.89-95.1999","article-title":"Variables that affect assays for plasma cytokines and soluble activation markers","volume":"6","author":"N Aziz","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-1759(98)00014-3","article-title":"Stability of immunoglobulin E (IgE) in stored obstetric sera","volume":"213","author":"CE Henderson","year":"1998","journal-title":"J Immunol Methods"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2710.2008.00878.x","article-title":"Prevalence and determinants of pharmacy shopping behaviour","volume":"33","author":"H Buurma","year":"2008","journal-title":"J Clin Pharm Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T02:20:07Z","timestamp":1596680407000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077587"}},"subtitle":[],"editor":[{"given":"Lionel\u00a0G","family":"Filion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,16]]},"references-count":90,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077587","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,16]]}}}